Enhancer ID: | E_02_0662 |
Species: | human |
Position : | chrX:67541427-67543427 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Muscle invasive disease (muscle invasive disease) |
Pubmed ID: | 31234917 |
Enhancer experiment: | PCR, Western blot, gel electrophoresis |
Enhancer experiment description: | ASC-J9? increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals. |
Target gene : | AR,BCL2(Bcl-2,PPP1R50),BAX |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | ASC-J9? increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals.;The combined therapy increases the expression of the pro-apoptosis BAX gene and cell cycle inhibitor p21 gene, yet suppresses the expression of the pro-survival BCL2 gene in miBCa cells.;The combined therapy increases the expression of the pro-apoptosis BAX gene and cell cycle inhibitor p21 gene, yet suppresses the expression of the pro-survival BCL2 gene in miBCa cells. |
TF name : | -- |
TF experiment: | PCR,Western blot,???? |
TF experiment description: | ASC-J9? increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals.;The combined therapy increases the expression of the pro-apoptosis BAX gene and cell cycle inhibitor p21 gene, yet suppresses the expression of the pro-survival BCL2 gene in miBCa cells.;The combined therapy increases the expression of the pro-apoptosis BAX gene and cell cycle inhibitor p21 gene, yet suppresses the expression of the pro-survival BCL2 gene in miBCa cells. |
Enhancer function : | ASC-J9? increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
ASC-J9? increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|